Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years

Name: Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years
License: Public Domain

Cinnagen

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid

covid-19

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 414358
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.